We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Software to predict the right dose for vancomycin in a clinical environment—A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi‐experimental study by Luqman Vali et al.
- Authors
Dijkstra, Jacob A.; Veldkamp, Agnes I.; Sieswerda, Elske; van Agtmael, Michiel
- Abstract
Generally accepted vancomycin PK/PD targets are an AUC/MIC > 400 or a trough serum or plasma level (C SB trough sb )/MIC > 10-15.1 Using the AUC/MIC as predicting parameter requires the use of specialized software to calculate the AUC on intermittent dosing regimens, but is generally accepted as the most appropriate PK/PD-index of vancomycin. Software to predict the right dose for vancomycin in a clinical environment - A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study by Luqman Vali et al Vancomycin is frequently used to treat Staphylococcal infections resistant to beta-lactam antibiotics.
- Subjects
VANCOMYCIN; ACUTE kidney failure; BETA lactam antibiotics
- Publication
British Journal of Clinical Pharmacology, 2021, Vol 87, Issue 9, p3481
- ISSN
0306-5251
- Publication type
Article
- DOI
10.1111/bcp.14765